Can combined chemo-radiation be started after induction chemotherapy in the curative treatment of stage III non-small cell lung carcinoma (NSCLC)? A multicenter, phase II study 5-year update

被引：0
|
作者：
Faria, S.
Owen, S. P.
Soulieres, D.
Del Vecchio, P.
Ofiara, L.
Ayoub, J. M.
Charpentier, D.
Gruber, J.
Wan, J. F.
Souhami, L.
Kopek, N.
Hirsh, V.
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada
[3] McGill Univ, Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e17507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17507
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer
    Ramalingam, S. S.
    Kotsakis, A.
    Tarhini, A. A.
    Heron, D. E.
    Smith, R.
    Friedland, D.
    Petro, D. P.
    Raez, L. E.
    Brahmer, J. R.
    Greenberger, J. S.
    Dacic, S.
    Hershberger, P.
    Landreneau, R. J.
    Luketich, J. D.
    Belani, C. P.
    Argiris, A.
    LUNG CANCER, 2013, 81 (03) : 416 - 421
  • [22] The consolidation study with docetaxel after combined chemoradiotherapy in Stage III B non-small cell lung carcinoma
    Mayadagli, Alpaslan
    Cepni, Kimia
    Ozkan, Alper
    Kocak, Mihriban
    Caglayan, Benan
    Salepci, Taflan
    Aykanat, Ahmet
    ANNALS OF ONCOLOGY, 2004, 15 : 174 - 174
  • [23] Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer
    van Baardwijk, Angela
    Reymen, Bart
    Wanders, Stofferinus
    Borger, Jacques
    Ollers, Michel
    Dingemans, Anne-Marie C.
    Bootsma, Gerben
    Geraedts, Wiel
    Pitz, Cordula
    Lunde, Ragnar
    Peters, Frank
    Lambin, Philippe
    De Ruysscher, Dirk
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (15) : 2339 - 2346
  • [24] Phase II trial with carboplatin/gemcitabine induction chemotherapy followed by radiotherapy concomitantly with paclitaxel/gemcitabine in stage III non-small cell lung cancer (NSCLC).
    Hirsh, V.
    Duclos, M.
    Souhami, L.
    Del Vecchio, P.
    Ofiara, L.
    Faria, S.
    Ayoub, J.
    Charpentier, D.
    Portelance, L.
    Soulieres, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 398S - 398S
  • [25] Comparison of effectiveness between chemotherapy alone versus chemo-radiotherapy in stage III non-small cell lung cancer: A phase II study
    Stathopoulos, GP
    Malamos, NA
    Antonadou, D
    Throuvalas, NA
    Thalassinos, N
    Zoitopoulos, M
    ONCOLOGY REPORTS, 1997, 4 (01) : 119 - 122
  • [26] First line treatment of non-small cell lung carcinoma (NSCLC) with docetaxel and vinorelbine: A phase II study
    Kourousis, C
    Androulakis, N
    Kakolyris, S
    Vamvakas, L
    Heras, P
    Metaxaris, G
    Maltezakis, G
    Chalkiadakis, G
    Vlachonikolis, J
    Hatzidaki, D
    Samonis, G
    Georgoulias, V
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 673 - 679
  • [27] Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer
    Blackstock, A. William
    Ho, Coty
    Butler, Jerome
    Fletcher-Steede, June
    Case, L. Douglas
    Hinson, William
    Miller, Antonius A.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (05) : 434 - 440
  • [28] Phase II trial of gemcitabine and cisplatin (GC) as neoadjuvant chemotherapy in unresectable stage III non-small cell lung cancer (NSCLC).
    Crino, L
    Mazzoni, F
    Maestri, A
    Calandri, C
    Selvaggi, G
    Scagliotti, GV
    De Marinis, F
    Gregorc, V
    Darwish, S
    Tonato, M
    ANNALS OF ONCOLOGY, 2000, 11 : 108 - 108
  • [29] Update on survival in a phase IB/II study of DMXAA combined with carboplatin and paclitaxel in non-small cell lung cancer (NSCLC)
    Von Pawel, J.
    Reck, M.
    McKeage, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 16 - 16
  • [30] Phase II study of induction docetaxel/cisplatin followed by concurrent pulsed docetaxel chemoradiation for stage III non-small cell lung cancer (NSCLC)
    Pandya, Kishan J.
    Chen, Yuhchyau
    Hyrien, Ollieier
    Smudzin, Therese
    ANNALS OF ONCOLOGY, 2006, 17 : 229 - 229
12345